Mednet Logo
HomeEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

Is it safe to continue administering Prolia per schedule for osteoporosis treatment shortly after a patient has undergone extensive spinal surgery?

1
2 Answers

Mednet Member
Mednet Member
Endocrinology · Providence John Wayne Cancer Institute Endocrinology

There is no evidence that spine surgery is a contraindication to receiving Prolia. If the bone was incised, Prolia could help healing.

What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?

1
1 Answers

Mednet Member
Mednet Member
Infectious Disease · UT Southwestern

I would consider it if the patient had diabetes. But there is not much data on this question.

Is it possible for certain individuals with osteoporosis to be a denosumab "non-responder"?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Milwaukee Va Medical Center

As far as I know, there are non-responders to every drug. There are 2 considerations that you should particularly consider, and which you could address. First, does the patient have an unrecognized secondary cause for low bone mass or fracture? It is really important to reevaluate a patient who is n...

Would you recommend statin initiation in a young adult patient (age < 40) with type 1 diabetes mellitus and LDL cholesterol levels greater than 100 without any cardiovascular risk factors?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Mayo Clinic College of Medicine and Science

The recommendations are to start statins in young adults with type 1 DM if duration of diabetes is over 20 years.

Would you order a fibroscan to screen for MASLD in patients with insulin resistance but normal LFTs?

1 Answers

Mednet Member
Mednet Member
Endocrinology · University of Missouri School of Medicine

Suggest that you check the FIB-4 score first.

Can combined oral contraceptive use cause falsely elevated 24-hour urine-free cortisol?

1
2 Answers

Mednet Member
Mednet Member
Endocrinology · Johns Hopkins Endocrinology and Pituitary Center

UFC is an expression of free cortisol. It should not be affected by oral estrogen.

How long should T3 be continued in hypothyroid patients who received no symptomatic benefit after starting T3/T4 combination therapy?

2
2 Answers

Mednet Member
Mednet Member
Endocrinology · Endocrinology Clinics Of Texas

I stop at next visit and increase T4 replacement accordingly.

Does the presence of osteoporosis change the extent of workup that should be performed for an older patient with otherwise serologically low-risk MGUS?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Washington, Fred Hutchinson Cancer Research Center

In brief - no, it shouldn't. While some previous studies have suggested that patients with MGUS are more likely to develop osteoporosis than those who don't, this is often related to confounders when MGUS is picked up clinically - in other words, patients with comorbidities that prompt a doctor to l...

Would elevated bone mineral density/T-score be enough to make a diagnosis of osteopetrosis?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

You should not make the diagnosis of osteopetrosis based on a high bone density. There are several causes for high bone density including the autosomal recessive genetic disorder sclerostosis which is caused by mutations in the STOST gene which prevents the production of functional sclerostin.

What is the therapeutic role and blood glucose lowering capability of bromocriptine and cholestyramine for the treatment of Type 2 diabetes?

2 Answers

Mednet Member
Mednet Member
Endocrinology · Banner University Medical Center

In the 15 or so years since bromocriptine and cholestyramine were approved for the treatment of hyperglycemia in T2DM, I have never prescribed them for this indication. I also have very rarely used other FDA-approved glucose-lowering agents including meglitinides, alpha-glucosidase inhibitors and am...